Description

Mylotarg is a medication used in the treatment of acute myeloid leukemia (AML). It is a targeted therapy that combines a cytotoxic agent with a monoclonal antibody to specifically attack cancer cells.

Interpreter Notes

Interpreters should be aware that Mylotarg may be referred to in various contexts, including clinical trials and treatment discussions. It is important to maintain a formal register and avoid colloquial terms. Stick to the glossary term 'Mylotarg' in all formal contexts to prevent confusion with other medications.

Example Sentences

EN: The oncologist recommended Mylotarg as part of the treatment plan for the patient with acute myeloid leukemia.

ES: El oncólogo recomendó Mylotarg como parte del plan de tratamiento para el paciente con leucemia mieloide aguda.

Common Interpreter Mistakes

Confusing Mylotarg with similar-sounding medications; misidentifying it as a treatment for other types of leukemia; using informal language when discussing the medication.